• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: PROGENIKA BIOPHARMA, S.A ID CORE XT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

PROGENIKA BIOPHARMA, S.A ID CORE XT Back to Search Results
Model Number 1020220034
Device Problems False Positive Result (1227); Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 07/28/2021
Event Type  malfunction  
Manufacturer Narrative
The investigation is still on-going.No conclusion is available for this malfunction.
 
Event Description
The customer reported a possible discrepancy.The serological phenotype was s (upper case) negative,s positive but when tested with id core xt resulted phenotype was s (upper case) positive,s positive.
 
Manufacturer Narrative
B6: the genomic dna sample was sent to grifols ih center for dna sequencing of gypb exons 1-2, 4-6 and pseudo-exon 3.Two variants were found: gypb: c.251g>c when alone has only been described on the gypb*s allele (vox sang.2017 jun;112 suppl 1:55) and doesn't affect the expression of the s antigen and gypb: c.271-2a>t in intron 5 that has not been previously reported.Although its effect is unknown, the most probable location of this variant is on the allele gypb*s, based on the serology results, s (upper case) negative.Id core xt reported a predicted s (upper case) positive phenotype, but the serology data from the user is s-, due to the not interrogated variant gypb: c.271-2a>t.This false positive result obtained by id core xt is considered a discrepant result and then a malfunction.This limitation is covered by the general assay limitation described in the id core xt package insert (limitation 1 and 10).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ID CORE XT
Type of Device
ID CORE XT
Manufacturer (Section D)
PROGENIKA BIOPHARMA, S.A
ibaizabal bidea, edificio 504
parque tecnológico de bizkaia
derio, bizkaia 48160
SP  48160
Manufacturer (Section G)
PROGENIKA BIOPHARMA, S.A
ibaizabal bidea, edificio 504
parque tecnológico de bizkaia
derio, bizkaia 48160
SP   48160
Manufacturer Contact
diego tejedor
ibaizabal bidea, edificio 504
parque tecnológico de bizkaia
derio, bizkaia 48160
SP   48160
MDR Report Key12516361
MDR Text Key272904907
Report Number3006413195-2021-00011
Device Sequence Number1
Product Code PEP
Combination Product (y/n)N
Reporter Country CodeSP
PMA/PMN Number
BP170154
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Distributor
Reporter Occupation Other
Type of Report Initial,Followup
Report Date 11/19/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/22/2021
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date02/05/2022
Device Model Number1020220034
Device Lot Number0203000023
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? No
Date Manufacturer Received10/21/2021
Was Device Evaluated by Manufacturer? No
Date Device Manufactured11/10/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-